Technical Analysis for ATHE - Alterity Therapeutics Limited

Grade Last Price % Change Price Change
F 1.80 2.27% 0.04
ATHE closed up 2.27 percent on Monday, March 18, 2024, on 26 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Gapped Up Strength 0.00%
20 DMA Resistance Bearish 2.27%
Fell Below 20 DMA Bearish 0.00%
Crossed Above 20 DMA Bullish -3.74%
MACD Bullish Signal Line Cross Bullish -3.74%
Pocket Pivot Bullish Swing Setup -3.74%
Gapped Up Strength -3.74%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 9 hours ago
Possible Inside Day about 9 hours ago
Rose Above 20 DMA about 11 hours ago
20 DMA Support about 11 hours ago
Gap Up Partially Closed about 12 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Alterity Therapeutics Ltd formerly known as Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Neuroscience Alzheimer's Disease Gastrointestinal Parkinson's Disease Neurology Toxicology Treatment Of Parkinson's Disease Huntington's Disease Movement Disorders Pathology Anatomical Pathology Brain Cancer Neuropathology Toxicology Testing Treatment Of Alzheimer's

Is ATHE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.41
52 Week Low 1.55
Average Volume 44,007
200-Day Moving Average 2.47
50-Day Moving Average 1.92
20-Day Moving Average 1.81
10-Day Moving Average 1.74
Average True Range 0.16
RSI (14) 46.81
ADX 10.69
+DI 23.25
-DI 18.50
Chandelier Exit (Long, 3 ATRs) 1.67
Chandelier Exit (Short, 3 ATRs) 2.03
Upper Bollinger Bands 2.05
Lower Bollinger Band 1.57
Percent B (%b) 0.48
BandWidth 26.34
MACD Line -0.06
MACD Signal Line -0.08
MACD Histogram 0.0142
Fundamentals Value
Market Cap 13.15 Million
Num Shares 7.3 Million
EPS -1.86
Price-to-Earnings (P/E) Ratio -0.97
Price-to-Sales 3.73
Price-to-Book 0.99
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.92
Resistance 3 (R3) 1.93 1.90 1.90
Resistance 2 (R2) 1.90 1.87 1.90 1.89
Resistance 1 (R1) 1.85 1.85 1.84 1.84 1.89
Pivot Point 1.82 1.82 1.81 1.82 1.82
Support 1 (S1) 1.77 1.79 1.76 1.76 1.71
Support 2 (S2) 1.74 1.77 1.74 1.71
Support 3 (S3) 1.69 1.74 1.70
Support 4 (S4) 1.68